Psychedelic trips often unfold without issues, but what if a trip needs to be stopped? Drugs such as benzodiazepines and antipsychotics are recommended as rescue medications and have been around for decades. Can ketanserin be used as a more targeted trip stopper?
Psychedelics may hold the key to a novel PTSD treatment.
Experts say COMPASS’ analysis overlooked one of the crystal forms present in their sample.
Even at therapeutic doses, ibogaine may cause potentially life-threatening cardiac arrhythmia. Science is beginning to unravel the pharmacological factors that may underlie ibogaine-induced cardiotoxicity.
Although there are distinct differences between our species, the mouse serotonin 2A receptor plays a crucial role in human psychedelic drug research.
Scientists know there’s more to magic mushrooms than just psilocybin. But as the psychedelic industry begins taking shape, could the mushroom itself be left behind?
The path toward therapeutic psychedelic-based drugs is becoming clearer as scientists understand more about how they are processed in the body.
This innovation may pave the way for pharmaceuticals that act like psychedelics at the 5-HT2A receptor but don’t have hallucinogenic effects.
Sensitive to LSD? It may be in your genes.
How do psychedelics interact with the human body beyond brain cells?